Select Medical Holdings (SEM) Reports In-Line Q1 EPS; Offer FY19 EPS/Revenue Guidance

Select Medical Holdings (NYSE: SEM) reported Q1 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.33 billion.

GUIDANCE:

Select Medical Holdings sees FY2019 EPS of $0.97-$1.13, versus the consensus of $1.04. Select Medical Holdings sees FY2019 revenue of $5.2-5.4 billion, versus the consensus of $5.29 billion.

Select Medical reaffirms its 2019 business outlook, provided most recently in its February 21, 2019 press release, for net operating revenues and Adjusted EBITDA. Select Medical continues to expect consolidated net operating revenues for the full year 2019 to be in the range of $5.2 billion to $5.4 billion. Select Medical continues to expect Adjusted EBITDA for the full year 2019 to be in the range of $660.0 million to $700.0 million. Select Medical is adjusting its 2019 business outlook for fully diluted earnings per common share to include the first quarter 2019 non-operating gain and its related tax effects. Select Medical now expects fully diluted earnings per common share for the full year 2019 to be in the range of $1.00 to $1.16. Select Medical expects adjusted earnings per common share to be in the range of $0.97 to $1.13. Adjusted earnings per common share excludes the non-operating gain and its related tax effects.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Energy Fuels to acquire rare earth magnet maker VAC for $1.9 billion
• Jefferies Reinstates Talen Energy (TLN) at Hold